Novartis’ Exjade Label Expansion To Get Advisory Committee Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Indication for non-transfusion dependent thalassemia, a cluster of inherited blood disorders that cause mild anemia, will be reviewed by FDA’s Oncologic Drugs Advisory Committee Nov. 8.